IRIS - Res&Arch Institutional Research Information System - Research & Archive

Cellini, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.202
EU - Europa 960
AS - Asia 140
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 2.308
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.201
IE - Irlanda 427
IT - Italia 214
RU - Federazione Russa 75
FI - Finlandia 70
HK - Hong Kong 66
RO - Romania 39
UA - Ucraina 30
CN - Cina 29
VN - Vietnam 24
DE - Germania 21
SE - Svezia 18
GB - Regno Unito 15
CH - Svizzera 13
FR - Francia 9
TR - Turchia 8
AT - Austria 7
GR - Grecia 6
BE - Belgio 5
LB - Libano 5
NL - Olanda 5
EU - Europa 4
UZ - Uzbekistan 3
BG - Bulgaria 2
ES - Italia 2
PL - Polonia 2
SG - Singapore 2
CA - Canada 1
CI - Costa d'Avorio 1
ID - Indonesia 1
KR - Corea 1
MY - Malesia 1
SC - Seychelles 1
Totale 2.308
Salva come PNG Salva come JPEG
Città #
Dublin 424
Chandler 285
San Mateo 161
Altamura 87
Medford 87
Princeton 87
Lawrence 83
Andover 72
Hong Kong 66
Wilmington 45
Perugia 39
Bucharest 33
Ann Arbor 29
San Paolo di Civitate 26
Dong Ket 24
Beijing 23
Saint Petersburg 22
Los Angeles 15
Norwalk 11
Des Moines 9
Falls Church 8
Helsinki 8
New York 8
Redmond 7
Kocaeli 6
Novosibirsk 6
Timisoara 6
Brussels 5
Redwood City 5
Assisi 4
Chicago 4
Woodbridge 4
Cambridge 3
Frankfurt Am Main 3
Lappeenranta 3
Milan 3
Moscow 3
Rome 3
Amsterdam 2
Boardman 2
Collazzone 2
Colle di Val d'Elsa 2
Den Haag 2
Edinburgh 2
Hanover 2
Houston 2
Jacksonville 2
Kazan 2
Lausanne 2
Madrid 2
Morrovalle 2
Padova 2
Shenzhen 2
Turin 2
Urbino 2
Verona 2
Vienna 2
Abidjan 1
Apo 1
Auxvasse 1
Bielefeld 1
Birmingham 1
Bologna 1
Castelfiorentino 1
Clearwater 1
Dearborn 1
Edmonton 1
Fairfield 1
Foggia 1
George Town 1
Groningen 1
Hangzhou 1
Hefei 1
Izmir 1
Kiev 1
Ludwigshafen 1
Medan 1
Menlo Park 1
Nagold 1
Nice 1
Philadelphia 1
Pordenone 1
San Diego 1
Seoul 1
Siena 1
Sligo 1
Sofia 1
Terni 1
Zevio 1
Totale 1.787
Salva come PNG Salva come JPEG
Nome #
Cyclo(His-Pro) inhibits NLRP3 inflammasome cascade in ALS microglial cells 62
Potential influence of cyclo(His-pro) on proteostasis: Impact on neurodegenerative diseases 60
Astrocytes regulate the expression of Insulin-Like Growth Factor 1 Receptor (IGF1-R) in primary cortical neurons during in vitro senescence 52
Molecular basis of primary hyperoxaluria: clues to innovative treatments 51
Identification by virtual screening and in vitro testing of human DOPA decarboxylase inhibitors. 47
The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 46
Tryptophan Co-Metabolism at the Host-Pathogen Interface 46
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 46
Crosstalk between long-term sublethal oxidative stress and detrimental inflammation as potential drivers for age-related retinal degeneration 46
The IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways 44
Selectively targeting key inflammatory pathways in cystic fibrosis 44
Anakinra restores cellular proteostasis by coupling mitochondrial redox balance to autophagy 42
Allele-specific Characterization of Alanine: Glyoxylate Aminotransferase Variants Associated with Primary Hyperoxaluria 40
Biochemical Characterization of Aspergillus fumigatus AroH, a Putative Aromatic Amino Acid Aminotransferase 39
Correlation between the molecular effects of mutations at the dimer interface of alanine–glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6 38
Biochemical properties and oxalate-degrading activity of oxalate decarboxylase from bacillus subtilis at neutral pH 38
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 37
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 37
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 36
Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. 36
Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase 36
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 35
Pyridoxal 5′-phosphate-dependent enzymes at the crossroads of host–microbe tryptophan metabolism 35
Folding Defects Leading to Primary Hyperoxaluria 34
Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I 34
Electrostatic interactions drive native-like aggregation of human alanine:glyoxylate aminostransferase 32
Characterization of C-S Lyase from C. diphtheriae: A Possible Target for New Antimicrobial Drugs 31
Amniotic fluid stem cell-derived extracellular vesicles are independent metabolic units capable of modulating inflammasome activation in THP-1 cells 31
Caenorhabditis elegans AGXT-1 is a mitochondrial and temperature-adapted ortholog of peroxisomal human AGT1: New insights into between-species divergence in glyoxylate metabolism 30
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analyses 30
Targeting Cystalysin, a Virulence Factor of Treponema denticola-Supported Periodontitis 29
A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase 29
Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach 29
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 28
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 28
A novel pathway for metabolism of the cardiovascular risk factor homoarginine by alanine:glyoxylate aminotransferase 2 28
Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects 28
Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis 27
The ILE56 mutation on different genetic backgrounds of alanine:glyoxylate aminotransferase: Clinical features and biochemical characterization 27
R180T variant of δ-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-ray and NMR studies provide insight into its catalytic features 26
Molecular and Cellular Studies Reveal Folding Defects of Human Ornithine Aminotransferase Variants Associated With Gyrate Atrophy of the Choroid and Retina 26
Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T 25
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 25
Radiation damage at the active site of human alanine:glyoxylate aminotransferase reveals that the cofactor position is finely tuned during catalysis 25
Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine 24
S-Glutathionylation at Cys328 and Cys542 Impairs STAT3 Phosphorylation 24
S-glutathionylation exerts opposing roles in the regulation of STAT1 and STAT3 signaling in reactive microglia 24
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 24
Natural and unnatural compounds rescue folding defects of human alanine:glyoxylate aminotransferase leading to Primary Hyperoxaluria Type I 23
Dimerization drives proper folding of human alanine:Glyoxylate aminotransferase but is dispensable for peroxisomal targeting 23
Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1 22
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 22
Pyridoxal 5’-Phosphate Enzymes as Targets for Therapeutic Agents 22
Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview. 22
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 22
Intracellular ascorbic acid enhances the DNA single-strand and toxicity induced by peroxynitrite in U937 cells 22
Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate 21
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 20
Evolutionary divergent suppressor mutations in conformational diseases 20
Treponema denticola cystalysin exhibits a significant alanine racemase activity accompanied by transamination: mechanistic implications 20
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 19
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 19
The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase 19
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 19
Tat-mediated delivery of human alanine:glyoxylate aminotransferase in a cellular model of Primary Hyperoxaluria Type I 18
Holo-and apocystalysin from Treponema denticola: two different conformations 18
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 18
Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin 18
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 18
Site-directed mutagenesis provides insight into racemization of alanine catlayzed by "Treponema denticola" cystalysin 18
Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli 18
Molecular and biochemical methods to assess the biological impact of Quantum Dots 18
S81 L and G170R mutations causing Primary Hyperoxaluria Type I in homozygosis and heterozygosis: an example of positive interallelic complementation. 18
PLP-Dependent Enzymes 17
Lysine 238 is an essential residue for alfa, beta- elimination catalyzed by "Treponema denticola" cystalysin 17
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 17
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 17
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 17
Molecular insights into primary hyperoxaluria Type I pathogenesis. 16
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 16
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 16
Treatment options in primary hyperoxaluria Type I 16
Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells 16
Oligomeric State and Thermal Stability of Apo- and Holo- Human Ornithine δ-Aminotransferase 16
Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line 15
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 15
Rapid profiling of disease alleles using a tunable reporter of protein misfolding 15
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 14
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 14
A multicentric consortium study demonstrates that dimethylarginine dimethylaminohydrolase 2 is not a dimethylarginine dimethylaminohydrolase 14
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 13
CRISPR/Cas9-mediated knock-out of AGXT1 in HepG2 cells as a new in vitro model of Primary Hyperoxaluria Type 1 13
Structural dynamics shape the fitness window of alanine:glyoxylate aminotransferase 12
Editorial: The role of cofactors in protein stability and homeostasis: Focus on human metabolism 11
Biochemical and Bioinformatic Studies of Mutations of Residues at the Monomer-Monomer Interface of Human Ornithine Aminotransferase Leading to Gyrate Atrophy of Choroid and Retina 10
Liver-directed gene therapy for ornithine aminotransferase deficiency 10
Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study 10
Primary hyperoxaluria in Italy: the past 30 years and the near future of a (not so) rare disease 8
Totale 2.543
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.274
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20198 0 0 0 0 0 0 0 0 0 0 5 3
2019/202064 10 2 2 0 2 1 2 2 12 10 18 3
2020/2021232 0 5 5 2 161 1 7 2 13 7 5 24
2021/2022639 2 97 7 4 14 2 15 244 24 30 93 107
2022/20231.180 89 251 10 87 81 82 1 48 491 1 36 3
2023/2024228 33 45 18 7 21 0 57 1 22 24 0 0
Totale 2.543